Hester Biosciences has submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Saturday, 31.10.2020 at 2:00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30.09.2020.
The above information is a part of company’s filings submitted to BSE.